ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2544

How Does a Younger Age at the Onset of Sjögren’s Syndrome (pSS) Influence the Clinical Presentation and the Clinical Course of the Disease?

Chiara Baldini1, Luca Quartuccio2, Elena Bartoloni-Bocci3, Roberta Priori4, Francesco Carubbi5, Alessia Alunno3, Roberto Gerli3, Guido Valesini4, Salvatore De Vita2 and Stefano Bombardieri6, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy, 3Clinical and Experimental Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 4Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, 5Rheumatology Clinic, University of L'Aquila, L'Aquila, Italy, 6Rheumatology Unit, University of Pisa, Pisa, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjogren's Syndrome: Clinical Science

Session Type: Abstract Submissions (ACR)

Background/Purpose: (1) To analyze the clinical presentation and the clinical course of Sjögren’s Syndrome (pSS) in Caucasian patients with an “early-onset” pSS and (2) to compare the characteristics of the disease between this group of patients and a control group of patients with pSS and a “typical onset” of the disease.

Methods:

A retrospective systematic search through an Italian computerized pSS database, including 1445 patients, was performed in order to select the patients with an “early-onset” of the disease who were defined as those patients aged below the 10th percentile at the time of pSS diagnosis. All the patients enrolled in the database have been recruited at 5 Rheumatology University Italian medical centers and the data have been systematically entered in a standardized form and updated at regular intervals during follow-up since 2009. For all patients, the following parameters were retrieved: age at diagnosis, sex, disease duration, glandular and extra-glandular disease-related manifestations, laboratory features, serological profiles, medical treatments and lymphoproliferative complications. Categorical variables were compared using chi square test; continuous variables were compared using Student’s t-test. A 2-tailed value of p < 0.05 was taken to indicate statistical significance.

Results:

The systematic search selected 1192 pSS patients out of the entire cohort (AECG 2002). Median (IQR) age at pSS diagnosis was 52 (42-62) years and the tenth percentile was 33 years. By using the tenth percentile as a cut-off, we identified 125/1192 (10.5%) as the “early-onset” group whereas the remaining 1067/1192 (89.5%) represented the control group. Median (IQR) disease duration was significantly longer in the “early-onset” group (7 (3-14) versus 3 (1-8) years, p≤0.0001).  Patients with an early disease onset presented a lower frequency of subjective dry mouth (p=0.003) and a higher prevalence of parotid enlargement (p≤0.0001), Raynaud’s phenomenon (p=0.04) and tubular renal disease (p=0.04). Moreover, patients with an “early-onset” pSS presented more frequently a positivity for rheumatoid factor (RF) (p≤0.0001), anti-Ro/SS-A (p≤0.0001), and anti-La/SS-B antibodies (p≤0.0001), low C3 levels (p=0.006), hyper-gammaglobulinemia (p≤0.0001), and leukocytopenia (p=0.006). No differences were detected between the two groups regarding low C4 levels, cryoglobulins, purpura, peripheral nervous system involvement and lymphoproliferative complications.

Conclusion: The age at the onset of pSS may influence the diagnostic algorithm of the disease due to the lower prevalence of subjective sicca symptoms. Parotid enlargement, kidney involvement, laboratory and serological abnormalities seemed to be distinctive features of the “early-onset” pSS. However, despite the higher frequency of parotid gland enlargement, patients with “early-onset” pSS apparently did not present a phenotype at higher risk of lymphoma.  


Disclosure:

C. Baldini,
None;

L. Quartuccio,
None;

E. Bartoloni-Bocci,
None;

R. Priori,
None;

F. Carubbi,
None;

A. Alunno,
None;

R. Gerli,
None;

G. Valesini,
None;

S. De Vita,
None;

S. Bombardieri,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-does-a-younger-age-at-the-onset-of-sjogrens-syndrome-pss-influence-the-clinical-presentation-and-the-clinical-course-of-the-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology